James E Herndon Selected Research

B 9430

2/2002

Novel doublets in extensive-stage small-cell lung cancer: a randomized phase II study of topotecan plus cisplatin or paclitaxel (CALGB 9430).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Herndon Research Topics

Disease

117	Neoplasms (Cancer) 04/2022 - 01/2002
59	Glioma (Gliomas) 04/2022 - 03/2002
50	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2004
26	Leukemia 09/2019 - 01/2002
20	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2003
20	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 01/2002
15	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2003
11	Lung Neoplasms (Lung Cancer) 12/2021 - 06/2004
11	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2008 - 02/2002
9	Fatigue 04/2022 - 10/2010
8	Chronic Disease (Chronic Diseases) 04/2022 - 12/2008
6	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2002
6	Vomiting 12/2020 - 03/2008
6	Nausea 12/2020 - 03/2008
6	Lymphopenia (Lymphocytopenia) 01/2018 - 03/2011
6	Dyspnea (Shortness of Breath) 10/2015 - 04/2005
5	Melanoma (Melanoma, Malignant) 01/2013 - 04/2006
4	Disease Progression 04/2019 - 07/2002
4	Diarrhea 07/2012 - 01/2004
4	Hypoxia (Hypoxemia) 04/2011 - 01/2008
4	Weight Loss (Weight Reduction) 09/2009 - 01/2006
4	Neutropenia 06/2009 - 01/2006
3	Meningioma (Meningiomas) 05/2022 - 01/2012
3	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2006
3	Thrombocytopenia (Thrombopenia) 03/2012 - 10/2002
3	Carcinogenesis 09/2011 - 04/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2010 - 03/2006
3	Febrile Neutropenia 06/2009 - 01/2006
3	Malignant Mesothelioma 06/2005 - 05/2004
3	Carcinoma (Carcinomatosis) 11/2004 - 01/2002
2	Necrosis 01/2022 - 10/2017
2	Lymphoma (Lymphomas) 04/2020 - 08/2013
2	Residual Neoplasm 09/2018 - 11/2010
2	Medulloblastoma 09/2018 - 12/2004
2	Hemorrhage 01/2012 - 06/2011

Drug/Important Bio-Agent (IBA)

30	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 02/2003
23	Bevacizumab (Avastin)FDA Link 04/2019 - 02/2007
20	Irinotecan (Camptosar)FDA LinkGeneric 04/2019 - 04/2004
18	ErbB Receptors (EGF Receptor)IBA 02/2014 - 01/2004
16	epidermal growth factor receptor VIIIIBA 01/2019 - 01/2008
11	VaccinesIBA 10/2020 - 11/2008
11	AntigensIBA 01/2018 - 04/2006
11	Monoclonal AntibodiesIBA 08/2012 - 03/2002
9	Carboplatin (JM8)FDA LinkGeneric 03/2012 - 07/2002
9	Paclitaxel (Taxol)FDA LinkGeneric 11/2008 - 02/2002
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
7	Cisplatin (Platino)FDA LinkGeneric 11/2008 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 04/2015 - 12/2004
6	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
6	Tyrosine Kinase InhibitorsIBA 07/2012 - 01/2004
6	O(6)-benzylguanineIBA 10/2009 - 05/2002
5	Chimeric Antigen ReceptorsIBA 01/2019 - 01/2014
5	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 01/2008
4	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 06/2021 - 07/2014
4	AntiemeticsIBA 05/2020 - 07/2014
4	Messenger RNA (mRNA)IBA 01/2020 - 03/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 08/2010
4	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2014 - 02/2004
4	Immunotoxins (Immunotoxin)IBA 07/2011 - 01/2008
4	Etoposide (VP 16)FDA LinkGeneric 06/2011 - 02/2005
4	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
4	Vinorelbine (Navelbine)FDA LinkGeneric 06/2007 - 10/2002
3	Ondansetron (Zofran)FDA LinkGeneric 12/2020 - 01/2017
3	Dasatinib (BMS 354825)FDA Link 01/2020 - 07/2012
3	Adenosine Triphosphate (ATP)IBA 01/2020 - 12/2005
3	EnzymesIBA 01/2019 - 04/2005
3	MethyltransferasesIBA 01/2019 - 10/2005
3	Palonosetron (Aloxi)FDA Link 01/2017 - 07/2014
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2012 - 01/2010
3	O(6)-Methylguanine-DNA MethyltransferaseIBA 12/2009 - 05/2002
3	TabletsIBA 06/2009 - 12/2008
3	Gefitinib (Iressa)FDA Link 02/2006 - 01/2004
3	Topoisomerase I InhibitorsIBA 10/2005 - 04/2004
2	Aprepitant (Emend)FDA Link 12/2020 - 05/2020
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 07/2014
2	Interleukin-2 (IL2)IBA 01/2019 - 01/2012
2	Vorinostat FDA Link 04/2018 - 01/2018
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2018 - 03/2014
2	Single-Chain AntibodiesIBA 01/2018 - 07/2011
2	Oxygen (Dioxygen)IBA 10/2015 - 09/2010
2	Clostridium perfringens epsilon-toxinIBA 02/2015 - 01/2014
2	Alkylating AgentsIBA 08/2013 - 01/2013
2	Protein Subunit VaccinesIBA 01/2013 - 11/2010
2	CytokinesIBA 01/2012 - 03/2006
2	Epidermal Growth Factor (EGF)IBA 01/2012 - 01/2008
2	Peptides (Polypeptides)IBA 01/2012 - 11/2010
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2011 - 05/2009
2	Indicators and Reagents (Reagents)IBA 07/2011 - 01/2006

Therapy/Procedure

70	Therapeutics 04/2022 - 01/2002
41	Drug Therapy (Chemotherapy) 04/2022 - 01/2002
26	Radiotherapy 05/2022 - 10/2002
14	Immunotherapy 01/2021 - 11/2008
6	Induction Chemotherapy 09/2009 - 10/2002
5	Salvage Therapy 05/2022 - 09/2004
4	Catheters 12/2018 - 07/2002
4	Adjuvant Chemotherapy 06/2014 - 08/2003
4	Chemoradiotherapy 01/2011 - 10/2002
3	Aftercare (After-Treatment) 10/2017 - 08/2003
2	Exercise Therapy (Therapy, Exercise) 12/2021 - 01/2020